Document Detail

Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial.
MedLine Citation:
PMID:  20694277     Owner:  NLM     Status:  In-Process    
Administration of heparin in the secondary prevention of placental vascular complications is still experimental. In women with a previous placental abruption, we investigated the effectiveness of enoxaparin, a low-molecular-weight heparin, in preventing these complications. Between January 2000 and January 2009, 160 women from the NOHA First cohort, with previous abruptio placentae but no foetal loss during their first pregnancy and negative for antiphospholipid antibodies, were randomised to either a prophylactic daily dose of enoxaparin starting from the positive pregnancy test (n=80), or no enoxaparin (n=80). The primary outcome was a composite of at least one of the following: abruptio placentae, preeclampsia, birthweight < 5th percentile, or foetal loss after 20 weeks. Enoxaparin was associated with a lower frequency of primary outcome: 12.5% (n=10/80) vs. 31.3 % (25/80), p=0.004, adjusted hazard ratio = 0.37, 95% confidence interval (0.18-0.77), p=0.011. Enoxaparin was safe, with no obvious side-effect, no thrombocytopenia nor major bleeding event excess. This pilot study shows that enoxaparin given early during the second pregnancy decreases the occurrence of placental vascular complications in women with a previous placental abruption during their first pregnancy.
Jean-Christophe Gris; Céline Chauleur; Jean-Luc Faillie; Guillaume Baer; Pierre Marès; Pascale Fabbro-Peray; Isabelle Quéré; Jean-Yves Lefrant; Bassam Haddad; Michel Dauzat
Related Documents :
3651537 - Fetal metabolism and placental transfer of vasoactive intestinal peptide in sheep.
2231547 - Purification, partial characterization, and development of a specific radioimmunoassay ...
12634647 - Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
20123797 - Maternal-fetal conflict: rapidly evolving proteins in the rodent placenta.
8283447 - Secretion of immunoreactive beta-endorphin and gnrh by the pig uterus: effects of repro...
6175887 - Normal infant after combination chemotherapy including teniposide for burkitt's lymphom...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-05
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  104     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  771-9     Citation Subset:  IM    
Research team EA2992, Montpellier 1 University, Nîmes, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High platelet turnover and reactivity in renal transplant recipients patients.
Next Document:  The role of CD154 in haematopoietic development.